Press Release

CSRXP APPLAUDS FDA APPROVAL OF SECOND INTERCHANGEABLE BIOSIMILAR FOR INSULIN

Nov 18, 2022

Interchangeable Biosimilars Help Provide Patients with Greater Choice and More Read More

CSRXP: PFIZER’S EGREGIOUS VACCINE PRICE HIKE DEMONSTRATES URGENCY TO BUILD ON POSITIVE PROGRESS TO HOLD BIG PHARMA ACCOUNTABLE

Oct 21, 2022

Big Pharma Companies Want to Price-Gouge the American People and Health Care Read More

CSRXP: BIG PHARMA’S EGREGIOUS $158,000 PRICE TAG ON UNPROVEN ALS TREATMENT MIRRORS PRICE-GOUGING OF ADUHELM

Oct 6, 2022

Brand Name Drug Maker Amylyx Sets Price Tag For Relyvrio Between Five And 17 Read More

CSRXP: AMERICAN PATIENTS COUNTING ON CONGRESS TO BUILD ON POSITIVE PROGRESS TOWARD LOWERING DRUG PRICES, NOT GO BACKWARDS

Sep 26, 2022

Lawmakers Must Put Patients First And Reject Bogus Big Pharma Rhetoric Read More

CSRXP: MODERNA MUST BE PUT ON NOTICE THAT PATIENTS, POLICYMAKERS WOULD FIND SIX-FOLD VACCINE PRICE HIKE UNCONSCIONABLE

Sep 12, 2022

Big Pharma Giant Eyes Massive Price Hike on COVID-19 Vaccine Developed with Read More

CSRXP APPLAUDS PRESIDENT BIDEN FOR TAKING MAJOR STEP TOWARD HOLDING BIG PHARMA ACCOUNTABLE

Aug 16, 2022

Biden Administration and Congress Deliver Positive Progress on Longstanding Read More

CSRXP: CONGRESS TAKES MAJOR STEP TOWARD HOLDING BIG PHARMA ACCOUNTABLE, LOWERING DRUG PRICES FOR THE AMERICAN PEOPLE

Aug 12, 2022

Big Pharma Can No Longer Evade Accountability and Keep Prices High by Spending Read More

CSRXP APPLAUDS SENATE FOR MAJOR STEP TOWARD HOLDING BIG PHARMA ACCOUNTABLE AND LOWERING PRESCRIPTION DRUG PRICES

Aug 7, 2022

Drug Pricing Solutions in Inflation Reduction Act of 2022 Will Help Crack Down Read More

CSRXP: INSULIN ACT MAY PROVIDE SHORT TERM RELIEF FOR SOME PATIENTS BUT WON’T ADDRESS ROOT CAUSE OF OUT-OF-CONTROL DRUG PRICES

Jul 19, 2022

Congress Must Advance Bipartisan, Market-Based Solutions to Hold Big Pharma Read More

CSRXP: BIG PHARMA BRAZENLY INCREASES PRICES ON MORE THAN 100 DRUGS TO START JULY PRICE-GOUGING

Jul 12, 2022

Brand Name Drug Companies Begin Second Round of Biannual Price Hikes While Read More

CSRXP APPLAUDS MOMENTUM TOWARD HOLDING BIG PHARMA ACCOUNTABLE, LOWERING DRUG PRICES

Jun 29, 2022

Congress Should Swiftly Advance Solutions to Deliver Relief for Millions of Read More

CSRXP AD CAMPAIGN: AMERICAN PEOPLE HAVE WAITED LONG ENOUGH; CONGRESS MUST HOLD BIG PHARMA ACCOUNTABLE

Apr 28, 2022

Seven-Figure Campaign Calls on Lawmakers to Reject Big Pharma’s Blame Game Read More